Jul 27, 2023, 08:45 AM by

VectorBuilder, a leading gene delivery technology company, announced with its latest cash injection that it reached a $1 billion valuation. VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. It is also a full-service CRO and CDMO supporting customers in their entire drug discovery pipeline, with over 4000 institutional customers worldwide. Gene delivery technologies enable precise manipulation of genetic information in cells and organisms. Besides being the workhorse of life sciences research for many decades, gene delivery technologies can correct genetic disorders, develop personalized medicine, and even enhance crop yields. This has sparked tremendous interest among scientists, clinicians, and industry leaders, making it a sought-after area of innovation and investment.

Jul 27, 2023, 01:00 AM by User Not Found

Bio-IT World | Illumina announces the five founding members of the Alliance of Genomic Discovery and launches the newest version of DRAGEN software, the Allen Institute for Immunology and Eli Lilly team up to better understand disease molecules, and crowd-sourced neuroscience. Plus, product updates, partnerships, and acquisitions from Sinequa, Lifebit, Arrayjet, BioIVT, and more.

Jul 26, 2023, 07:57 AM by

Biovian, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a major investment of over €50 million to expand its manufacturing facility in Turku, Finland.

Jul 26, 2023, 01:00 AM by User Not Found

Bio-IT World | AI platform used for acute immune states, acquisitions, solutions portfolio expansion, and more.

Jul 25, 2023, 09:23 AM by

Signed by the CEOs of AstraZeneca, GSK, Merck, Novo Nordisk, Sanofi, Samsung Biologics, and the Chairman of Roche, the Health Systems Task Force is calling on suppliers to commit to joint, minimum climate and sustainability targets.

Jul 25, 2023, 09:23 AM by

TransCure bioServices has expanded its reach in the APAC region by signing a strategic partnership with leading South Korean preclinical research company Preclina Inc.

Jul 25, 2023, 01:00 AM by User Not Found

Bio-IT World | As industries further explore AI, an abundance of new projects and ideas surface, and it can be difficult to decide where to focus.

Jul 24, 2023, 10:12 AM by

Jul 24, 2023, 10:12 AM by

Jul 24, 2023, 10:12 AM by

Jul 24, 2023, 09:26 AM by

BioIVT’s standardized collection protocols and diverse donor base help facilitate molecular biomarker validation and ensure their clinical utility.

Jul 21, 2023, 12:16 PM by

On the heels of the announcement of Phase II clinical trials for the first generative AI drug for the devastating lung disease idiopathic pulmonary fibrosis (IPF), clinical-stage drug discovery biotech Insilico Medicine has announced another breakthrough – an inhalation solution for its anti-fibrotic small molecule inhibitor designed to give patients in need another treatment option.

Jul 21, 2023, 09:26 AM by

The gold standard in dsRNA detection now available to virology researchers worldwide

Jul 21, 2023, 09:26 AM by

Integrated DNA Technologies is revealing a new next generation sequencing (NGS) solution, the xGen™ Respiratory Virus Amplicon Panel, to support researchers as they combat the challenging diseases of today and prepare for the next pathogen of tomorrow. With 98.7% total genomic coverage of viral respiratory variants Respiratory Syncytial Virus (RSV) A, RSV B, Influenza A H1N1, Influenza A H3N2, Influenza B, and SARS-CoV-2, the uniquely configured single panel is designed to monitor the evolution and spread of these six viruses.

Jul 21, 2023, 09:26 AM by

TVM Capital Life Science together withTillotts Pharma has announced that the companies will jointly invest up to USD 28 million in the newly formed U.S.-based biotechnology company, Mage Biologics Inc.

Jul 20, 2023, 09:57 AM by

Jul 20, 2023, 09:32 AM by

AI Start-up Pioneering Generative AI for Healthcare Receives $13M in Early Funding, Adds Industry Luminaries as Advisors, and Kicks off Use Cases for Health Insurance Plans and Provider Systems

Jul 20, 2023, 01:00 AM by User Not Found

Bio-IT World | After exploring the infrastructure upheaval of the past year, the annual Trends from the Trenches session at Bio-IT World moved to questions of data and teams.

Jul 19, 2023, 09:08 AM by

Researchers share findings from eight new studies on ability of digital solutions to accelerate early detection of Alzheimer’s and other dementias

Jul 19, 2023, 09:08 AM by

AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer Adherence specialists join multi-stakeholder initiative to improve long-term pathways for cancer patients and meet the challenge of oral treatments.